New New Blocks Page

Request More Info

testing

testing
testing

<>Effectiveness of cystoscopy: The challenge for clinicians

The need

Each year over 7 million US patients present with hematuria and 2 million are referred to urology for evaluation. 75% of these patients present with microhematuria.

The challenge

While hematuria is the most common symptom of urothelial cancer, the incidence is low among microhematuria patients and around 95% of those cystoscopies yield a negative result.

<>A non-invasive test that delivers clinically actionable results

The sampling process

Cxbladder's non-invasive urine sampling system, with the option of in-home sample collection, is easy and convenient for patients to use, while supporting streamlined deployment in-clinic.

The Science

Cxbladder is an objective test that analyzes biomarker genes to help rule out urothelial cancer. With high sensitivity and NPV, Cxbladder delivers exceptional performance and clinically actionable results.

The Cxbladder Alternative

Lorem ipsum dolor sit amet consectetur. Nibh sit lectus metus est scelerisque porta. Pulvinar mollis sit bibendum egestas congue augue sit. Tristique volutpat leo vitae nisl lacus. Fermentum non tellus felis rutrum ut. Maecenas mi nam pellentesque et fusce vel cras amet. Euismod malesuada nisl vel enim iaculis ac et molestie ac. Egestas mauris tristique sem maecenas ipsum id.

Cxbladder tests for hematuria evaluation

We offer two products for hematuria evaluation – Cxbladder Triage, a frontline diagnostic optimized for rule out in primary care, and Cxbladder Detect, a test designed to enhance risk stratification and rule in/ rule out in secondary care. In an adjunctive role, Cxbladder Detect can also help confirm a diagnosis when other tests provide ambiguous results.

Spare patients the discomfort, anxiety, risk, and inconvenience of an invasive procedure.
Improve compliance with scheduled surveillance checks.
Focus your in-clinic resources on those that need care.
Empower your team and improve time utilization to maximize overall efficiency.

<>Optimize your clinical practice while improving the patient experience.

Optimize your clinical practice

The Cxbladder suite helps you prioritize your time and clinical resources on those that need it the most, streamlining practice workflow and increasing overall efficiency.

Improve the patient experience

With non-invasive sampling and the option of in-home sample collection, the Cxbladder suite optimizes practice workﬂow while delivering the best patient experience possible.

Cxbladder tests for hematuria evaluation

Spare patients the discomfort, anxiety, risk, and inconvenience of an invasive procedure.
Improve compliance with scheduled surveillance checks.
Focus your in-clinic resources on those that need care.
Empower your team and improve time utilization to maximize overall efficiency.

The Cxbladder Alternative

<>Test padding

95-97% of patients presenting with microhematuria do not have UC and 70-80% of cystoscopies can be safely avoided using a non-invasive Cxbladder test.
The Cxbladder suite of non-invasive genomic urine tests is optimized for the risk stratification and rule-out of UC in patients presenting with microhematuria. The tests help you improve the overall patient experience, while prioritizing your time and clinical resources to optimize practice workﬂow and improve efficiency.

<>The challenge

Each year over 7 million US patients present with hematuria and 2 million are referred to urology for evaluation. 75% of these patients present with microhematuria and are typically prescribed an invasive cystoscopy in accordance with AUA guidelines.
While hematuria is the most common symptom of urothelial cancer (UC), the incidence is low among microhematuria patients and around 95% of those cystoscopies yield a negative result.

<>Test

<>Featured resources

<>Test the padding

UroToday: Bridging the Gap in Microhematuria Evaluation

Featured resources

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo cons.

Grands Rounds in Urology

test

UroToday: From Science to Clinical Utility

test